Zobrazeno 1 - 10
of 127
pro vyhledávání: '"Ronald O. Valdiserri"'
Autor:
Ronald O. Valdiserri
Publikováno v:
Emerging Infectious Diseases, Vol 26, Iss 10, Pp 2477-2477 (2020)
Externí odkaz:
https://doaj.org/article/172d6b59475741b5a7d30a39942e1bbb
Autor:
Ronald O. Valdiserri
Publikováno v:
Emerging Infectious Diseases, Vol 12, Iss 6, Pp 1031-1032 (2006)
Externí odkaz:
https://doaj.org/article/d1d07dd09b4a499b9916ccac79e605cc
Autor:
Ronald O. Valdiserri
Publikováno v:
Emerging Infectious Diseases, Vol 14, Iss 4, Pp 694-694 (2008)
Externí odkaz:
https://doaj.org/article/5d5a5e7b4b6e42458d04883df3c7d18d
Autor:
Ronald O. Valdiserri M.D
Dawning Answers charts the legacy of the global HIV/AIDS epidemic to the theory and practice of public health. Richly detailed chapters describe how advances in techniques and startegies to monitor health events, develop public policy, set funding pr
Autor:
Ronald O. Valdiserri
Publikováno v:
Journal of public health management and practice : JPHMP. 29(1)
Publikováno v:
JAMA. 329:1637
This Viewpoint outlines the progress made toward eliminating hepatitis B and C but emphasizes the work that remains to prioritize diagnosis and treatment of populations disproportionately affected by viral hepatitis, including ensuring that there are
Autor:
David R. Holtgrave, Melanie A. Thompson, Carlos del Rio, Ronald O. Valdiserri, Seth C. Kalichman
Publikováno v:
AIDS and Behavior
COVID-19 has caused devastating health consequences and social inequities globally and in the United States. Unfortunately, the US has not developed a comprehensive National COVID-19 Strategy. In this editorial, we briefly review lessons about the de
Publikováno v:
Ann Intern Med
BACKGROUND: HIV Prevention Trials Network (HPTN) 083 demonstrated superiority of long-acting injectable cabotegravir (CAB-LA) compared to oral emtricitabine/tenofovir disoproxil fumarate (F/TDF) for HIV pre-exposure prophylaxis (PrEP). OBJECTIVE: To
Publikováno v:
AIDS and Behavior. 23:2899-2903
Publikováno v:
Journal of Community Health. 44:423-427